Strategic Initiative Overview

QMS Medical Allied Services Limited and Health Care At Home India Pvt Ltd (HCAH) have announced a strategic merger of their pharma services businesses, specifically their Patient Support Program (PSP) verticals. The PSP businesses of both companies will be merged into Saarathi Healthcare, which is a 100% subsidiary of QMS.

Transaction Structure and Combined Platform

  • The merger creates a scaled provider of patient support program solutions for pharmaceutical companies across India
  • Combined platform will operate 160+ Patient Support Programs
  • Impacts over 1.2 million+ patients
  • Supported by 2,000+ professionals across 35+ cities
  • Complementary capabilities span patient screening, enrolment, therapy initiation, adherence, patient assistance, and disease management

Operational Capabilities

The combined entity will be India's largest patient support platform, serving top Indian and MNC pharma companies with capabilities including:

  • Health and awareness camps
  • Disease screening
  • Enrolment
  • Disease management
  • Therapy initiation
  • Adherence monitoring
  • Patient assistance
  • Ongoing patient engagement

Market Context and Growth Opportunity

The global patient support services market is estimated at approximately US$70 billion. The India market is growing at a CAGR of 15-20% and is expected to reach approximately US$1 billion by 2030. This growth is driven by:

  • Tighter promotional regulations
  • Industry formalisation
  • Rising chronic disease prevalence
  • Increasing digital adoption
  • Greater focus on continuous patient monitoring and recovery

Management Commentary

Mahesh Makhija, Founder, Chairman & Managing Director, QMS Medical Allied Services Limited stated: "The combination brings together two complementary platforms with strong capabilities across patient support and engagement. By bringing these capabilities together, we aim to create greater scale, reach and execution capability for pharmaceutical companies while helping more patients access the support they need throughout their treatment journey. This initiative would also fortify the value creation for the shareholders at QMS."

Aditya Burman, Non-Executive Director, HCAH, and Director, Dabur India Ltd stated: "Patient support is increasingly becoming an integral part of the healthcare journey, particularly as chronic conditions require sustained engagement beyond the point of treatment initiation. The combination of HCAH's and QMS's capabilities creates a scaled platform with the reach, technology and execution capabilities to support patients and pharmaceutical partners across the continuum of care."

Strategic Objectives

The partnership is intended to:

  • Create a larger and more comprehensive platform
  • Maintain continuity for existing clients, programs and teams through the transition
  • Capture leadership position in the PSP market
  • Enable pharmaceutical companies to support patients across a broader range of touchpoints throughout the patient journey from identification to therapy adherence

Company Background

QMS Medical Allied Services Ltd is an integrated healthcare solutions company operating across healthcare products and services, providing capabilities spanning patient engagement, Patient Service Programs (PSPs), disease management, preventive healthcare initiatives, patient screening and medical camps, healthcare staffing, and medical and diagnostic solutions.

HCAH is one of India's leading rehabilitation and out-of-hospital care platforms, delivering physician-led recovery, home healthcare, elderly care and pharma-partnered Patient Support Programs across the country. HCAH is backed by Quadria Capital GP alongside Foundation PE, Temasek-backed ABC Impact and the Burman family.